Abstract
ABSTRACT Modern literature emphasises the enterprise innovation theory of balancing explorative and exploitative activities to control the moral hazards of technology investment. Many studies overlook the noisy perspective of innovation and offer various instruments for more or less innovation. We attempt to diverge the debate and unfold the sensitivity of managerial equity incentive schemes on the subject of the quality of innovation. Investment in patents and R&D is applied to account for quantity and quality innovation, respectively. Fixed-effects and logit regression modelling are used for basic estimations and a two-step system GMM is applied to control the endogeneity. The estimations validate that stock appreciation incentives are more sensitive to the quantity of innovation, whereas, stock options and restricted equity rights have a strong impact on the quality of innovation. Subsample analysis revealed that the explanatory power of our predictions is highly pronounced in large and young firms. Innovative firms are suggested to design the managerial equity incentive portfolio as per their technological choices. Firms should consider the sensitivity of equity incentive schemes to control effort ex-ante, especially to attain technology leadership and optimal corporate value in the long run.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
